ThursdayAug 14, 2025 11:50 am

ONAR Holdings Inc. (ONAR): Breaking Through Data Fragmentation Crisis

Multi-agent AI infrastructure partnership with IQSTEL addresses the fundamental challenge of isolated marketing data across platforms, creating unified intelligence for campaign optimization Retina.ai acquisition brings customer lifetime value prediction and churn forecasting capabilities to ONAR’s client roster, including brands like Unilever and Dollar Shave Club Three-phase deployment strategy transforms agency operations from reactive optimization to proactive performance enhancement through interconnected AI agents Marketing executives face a paradox that undermines billions in annual advertising investment. While artificial intelligence promises unprecedented campaign optimization capabilities, most marketing organizations operate with fragmented data ecosystems that render AI applications largely ineffective. Customer data sits isolated…

Continue Reading

ThursdayAug 14, 2025 10:00 am

While DeepSeek Shocked the Market, Has it Really Changed AI?

The launch of Chinese DeepSeek AI sent shockwaves through Silicon Valley earlier this year. Practically overnight, its flagship model, DeepSeek-R1, soared to the top of the U.S. App Store’s free downloads list.  The company claimed its chatbot could rival ChatGPT, and even more surprisingly, that it had been built for a fraction of the typical development cost.  The claims, paired with its instant popularity, triggered a historic sell-off in the U.S. stock market. Nvidia, a leading chipmaker, lost about $600 billion in value in a single day, the largest drop ever for an individual stock. Other AI-related companies also took…

Continue Reading

TuesdayAug 12, 2025 10:00 am

Why Companies Are Blending IT and HR Departments

A recent survey by workplace software provider Nexthink found that 64% of IT executives in large organizations expect their human resources and IT departments to merge within the next five years, largely because of advancements in AI.  At biotech firm Moderna, this shift is already in motion. The company’s chief people and digital technology officer, Tracey Franklin, oversees both IT and HR for its 5,000-plus employees. Her role covers traditional IT support as well as the digital tools needed for drug research, production, and sales.  Franklin says the old model kept HR focused on workforce planning and IT on fulfilling…

Continue Reading

FridayAug 08, 2025 10:00 am

Report Says Thousands Have Lost Jobs to AI

Artificial intelligence (AI) is growing into a serious challenge for workers in the U.S. employment landscape. According to a recent report from Challenger, Gray & Christmas, the growing use of generative AI by private companies has triggered over 10,000 redundancies since the start of the year.  The outplacement consultancy ranks AI among the top five causes of layoffs this year. The latest labor statistics reveal that employers added just 73,000 roles in July—far below what analysts had expected. For the first seven months of the year, private-sector job cuts crossed 806,000, marking the highest total in that period since 2020,…

Continue Reading

FridayAug 08, 2025 9:45 am

ONAR Holding Corp. (ONAR) Expands AI Capabilities Through IQSTEL Partnership to Launch Multiagentic Infrastructure

Interconnected network of AI agents fundamentally transforms how marketing agencies create value and scale their impact The infrastructure will be introduced in three key phases: operational streamlining, strategic enablement and creative augmentation ONAR’s sees collaboration as foundational to the company’s long-term vision of building an advanced AI-powered agency system ONAR Holding Corp. (OTCQB: ONAR), a marketing technology company focused on AI-powered growth solutions, has announced the expansion of its strategic partnership with IQSTEL Inc. (NASDAQ: IQST) and IQSTEL’s artificial intelligence subsidiary, Reality Border (ibn.fm/whT2b). The collaboration will lead to the development and phased rollout of a multiagentic operating infrastructure designed…

Continue Reading

ThursdayAug 07, 2025 10:30 am

D-Wave Quantum Inc. (NYSE: QBTS): 27% of Surveyed Business Leaders Expect $5M+ ROI from Quantum Optimization Within First Year

Survey by Wakefield Research and D-Wave shows 46% of surveyed business leaders expect $1 million to $5 million ROI from quantum optimization within the first year of adoption. 81% believe they have reached the limits of classical computing’s capabilities for optimization. 53% are planning to integrate quantum computing into their workflows, while 27% are considering it. Quantum optimization is seen as especially valuable in logistics, supply chain, manufacturing, planning and inventory, and R&D. 88% of participants said their organizations would “go above and beyond” for even a 5% improvement in optimization. A new survey released by D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”),…

Continue Reading

ThursdayAug 07, 2025 10:00 am

Water Scarcity Threatens AI Growth in the Gulf

The Gulf region is locked in a multitrillion-dollar pursuit to build global leadership in AI. Yet this ambition faces a formidable obstacle—access to water. Data centers supporting AI in Saudi Arabia, the UAE, and neighboring countries are guzzling massive volumes of water.  The region is projected to need roughly 426 billion liters each year by 2030—turning water shortages into a serious limitation for tech growth. The UAE alone is expected to consume roughly 61 billion liters each year.  According to the World Resources Institute, Qatar, the UAE, and Saudi Arabia are ranked among the most water-stressed nations globally. Daily water…

Continue Reading

ThursdayAug 07, 2025 9:00 am

Lantern Pharma Inc. (NASDAQ: LTRN) Completes Japanese Enrollment for LP-300 Phase 2 HARMONIC(TM) Trial Ahead of Schedule

The trial targets never-smoker non-small cell lung cancer (“NSCLC”) patients, a group with limited treatment options. Japan’s high incidence of never-smoker NSCLC makes it a strategic region for the trial. LP-300 is being tested alongside standard chemotherapy agents in patients who have relapsed after tyrosine kinase inhibitor therapy. Lantern's AI-driven approach may help identify and accelerate development of therapies in underserved cancer markets. Additional trial data from Taiwan and the U.S. is expected later in Q3 2025. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine oncology drug development, has completed targeted patient…

Continue Reading

WednesdayAug 06, 2025 12:10 pm

Lantern Pharma Inc. (NASDAQ: LTRN) Launches AI Tool to Predict Efficacy of Cancer Drug Combinations

Lantern Pharma has introduced an AI-powered module within its RADR(R) platform to assess DDA-DDRi combination therapies. The module uses genomic, transcriptomic, and clinical data, to predict treatment synergy and patient response, and supported the design of Lantern’s FDA-cleared Phase 1B/2 trial in triple-negative breast cancer. A review of 221 clinical trials informed the development of the predictive algorithm. Non-PARP DDRi combinations with DNA-damaging agents showed strong outcomes in specific cancer subtypes. Lantern is evaluating licensing opportunities to commercialize the module for broader oncology use. Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotechnology company leveraging artificial intelligence and machine learning to redefine…

Continue Reading

TuesdayAug 05, 2025 10:00 am

YouTube Taps AI Tech to Regulate Teens’ Use of the Platform

YouTube has announced that it is introducing a new tool aimed at identifying users who are under 18. The move is part of a broader effort to shield younger audiences from content that might not be appropriate for their age group.  The new feature uses AI to make educated guesses about a user’s age. Rather than relying solely on the birthdate tied to an account, it considers what kind of videos someone watches, the themes of those videos, and how long the account has been active. According to James Beser, YouTube’s product management director, this approach will help better identify…

Continue Reading